
BMS-794833
CAS No. 1174046-72-0
BMS-794833( BMS794833 )
Catalog No. M10589 CAS No. 1174046-72-0
BMS794833?is a potent ATP competitive inhibitor of Met/VEGFR2 with IC50 of 1.7 nM/15 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 43 | In Stock |
![]() ![]() |
5MG | 81 | In Stock |
![]() ![]() |
10MG | 138 | In Stock |
![]() ![]() |
25MG | 281 | In Stock |
![]() ![]() |
50MG | 509 | In Stock |
![]() ![]() |
100MG | 731 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameBMS-794833
-
NoteResearch use only, not for human use.
-
Brief DescriptionBMS794833?is a potent ATP competitive inhibitor of Met/VEGFR2 with IC50 of 1.7 nM/15 nM.
-
DescriptionBMS794833?is a potent ATP competitive inhibitor of Met/VEGFR2 with IC50 of 1.7 nM/15 nM; also inhibits Ron, Axl and Flt-3 with IC50<3 nM; shows selectivity over a panel of >200 RTKs, non-RTKs and serine/threonine kinases; inhibits the cell growth in GTL-16 gastric carcinomas with an IC50 of 39 nM; active in multiple tumor models.Solid Tumors Phase 1 Clinical.
-
In VitroBMS794833 inhibits Met receptor activated gastric carcinoma cell line, GTL-16, with an IC50 of 39 nM.
-
In VivoBMS-794833 is active by greater than 50% tumor growth inhibition for at least one tumor doubling time in the GTL-16 gastric carcinoma model. No toxicity is observed at any of the dose levels when administered once daily for a duration of 14 days.
-
SynonymsBMS794833
-
PathwayAngiogenesis
-
Targetc-Met/HGFR
-
RecptorMet|VEGFR2
-
Research AreaCancer
-
IndicationSolid Tumors
Chemical Information
-
CAS Number1174046-72-0
-
Formula Weight468.84
-
Molecular FormulaC23H15ClF2N4O3
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESC1=CC(=CC=C1C2=CNC=C(C2=O)C(=O)NC3=CC(=C(C=C3)OC4=C(C(=NC=C4)N)Cl)F)F
-
Chemical Name3-Pyridinecarboxamide, N-[4-[(2-amino-3-chloro-4-pyridinyl)oxy]-3-fluorophenyl]-5-(4-fluorophenyl)-1,4-dihydro-4-oxo-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
SAR125884 hydrochlor...
SAR125844 is a potent and selective MET kinase inhibitor with a favorable preclinical toxicity profile(IC50=4.2 nM).
-
MK-2461
MK-2461 is a potent multitargeted kinase inhibitor that preferentially inhibits c-Met with IC50 of 2.5 nM.
-
Telisotuzumab
Telisotuzumab(ABT-700) is a humanized recombinant antibody targeting the therapeutic hepatocyte growth factor receptor (MET) with high affinity for c-Met.Telisotuzumab has inhibitory effects on c-Met signaling and antitumor activity.